Lastly, ChIP found that Metrnl treatment led to decreased HDAC4 binding to GLUT4 promoters within HF cardiomyocytes, thereby increasing GLUT4 levels (Fig. 6K). This evidence concerns the gene SLC2A4 and hydrops fetalis.